The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
In one of the previous Vox Videos doesn't AS talks about licensing AVA6000? for $50 plus ongoing yearly payments, assuming there are at least 15 candidates, at similar valuations, as Cilla might say "its a looora , looora money"!
From Feb 22 Presentation
Starting dose 80mg/m2 AVA6000 - Equivalent to 54mg/m2 Doxorubicin.
So after D/E will the equivalent be 54mg x 1.5 = 81mg?
Will the next D/E be Fibonacci types i.e. 33% increase them 25% increase
Old but worth a watch
https://www.youtube.com/watch?v=h-aZQGQMRBY
Do we still have tie up with ADC Therapeutics
https://www.fiercebiotech.com/biotech/astrazeneca-helps-adct-to-200m-mega-round-to-push-anti-cancer-adcs-to-pivotal-data
https://avacta.com/collaboration-and-option-agreement-with-adc-therapeutics/
Hi I don't know if this has been posted previusly
https://avacta.com/interview-with-fiona-mclaughlin-avacta-chief-scientific-officer-therapeutics/
What does innovation in healthcare mean?
Introduction. Innovation can be defined as invention + adoption + diffusion. In healthcare, it may be a novel idea, product, service or care pathway that has clear benefits when compared to what is currently done. Successful innovations often possess two key qualities: they are both usable and desirable.
This part is interesting
"Separately, a letter released by the MHRA under the Freedom of Information Act made clear that lateral flow test kits of the type which Johnson would have used daily under the pilot scheme were not authorised for daily use unless part of an approved study."
Which test would it be?
So if you had 22000 share previously, you would have 100 share after consolidation.
There was a bond holder that posted on advfn, cant remember name or what holding.
What is the latest water cut, anybody know?
What's the 200 dma? take-over by Christmas would be my guess.